Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: Modulation by a selective plasma kallikrein inhibitor

Proceedings of the Association of American Physicians

Volumn 109, Issue 1, 1997, Pages 10-22

  Colman, R W ^a   Stadnicki, A ^a   Kettner, C A ^a   Adam, A A ^a   Dela Cadena, R A ^a   Sartor, R B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

inflammation; Kallikrein inhibitors; kininogen

Indexed keywords

ACUTE PHASE PROTEIN; ENZYME INHIBITOR; HUMAN SERUM ALBUMIN; KALLIKREIN; KALLIKREIN INHIBITOR; KININ; KININOGEN; P 8720; PEPTIDE; PEPTIDOGLYCAN POLYSACCHARIDE; PREKALLIKREIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; CONTROLLED STUDY; ENTEROCOLITIS; FEMALE; GENETIC SUSCEPTIBILITY; KALLIKREIN KININ SYSTEM; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; REVIEW; STRAIN DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION; SYNOVITIS;

ACUTE-PHASE PROTEINS; ANIMALS; ARTHRITIS; BORON COMPOUNDS; DISEASE MODELS, ANIMAL; ENTEROCOLITIS; ENZYME INHIBITORS; FEMALE; HUMANS; INFLAMMATION; JOINTS; KALLIKREINS; KININOGENS; KININS; OLIGOPEPTIDES; RATS; RATS, INBRED BUF; RATS, INBRED LEW;

EID: 0030942022     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)